“The Reply to the Letter to the Editor Regarding: ‘The Autologous CaTeVac Dendritic Cell Vaccine in Patients With Melanoma: Final Results of the DENDRON-01 Study’”. Voprosy onkologii 72, no. 1 (March 11, 2026): OF-2568. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/1-26-Reply-to-the-Letter.